The MOF derivative was fabricated into a fluorescent nanoprobe, drDNA-BUT-88, which could identify dual tumor biomarkers (i.e., MUC-1 and miRNA-21) in breast cancer cells (MCF-7 cells). This evidence concerns the gene MUC1 and breast carcinoma.